-
NIH Funds Brain-Computer Implant Device
A developer of implanted devices to record signals from brain cells received funding to advance a smaller and more durable electrode array.
-
Crispr Licensed for Eye Disease Gene Therapies
A developer of inherited eye disease therapies is acquiring rights to the gene editing technology Crispr for treatments that work inside the eyes.
-
Small Biz Grant to ID Digital Biomarkers for Alzheimer’s
National Institutes of Health is awarding a grant to identify indicators of Alzheimer’s disease in a company’s collecting of life stories from older people.
-
Consider A Franchise for Your New Business Venture
If you’re considering purchasing a franchise, you should be aware of the risks and the benefits before making your decision.
-
Lab Demonstrates 3-D Printed Tissue, Blood Vessel Implant
A biomedical engineering team transplanted into a lab rat synthetic tissue with blood vessels made by three-dimensional printing.
-
Infographic – Cruising Biotech Index Takes Late Dip
NBI, an indicator of investor sentiment in the industry, continued its choppy climb through most of the third quarter, only to start another decline in late September.
-
FDA Halts Off-the-Shelf T-Cell Cancer Trials
The Food and Drug Administration stopped a company’s clinical trials of off-the-shelf engineered T-cells after a patient showed an abnormal chromosomal reaction.
-
Precision Neuroscience Company Starts-Up, Raises $500M
A new company is underway developing more precise therapies for psychiatric and neurodegenerative diseases based on genetics and data science.
-
Partnership Seeks Lower-Cost Protein Drugs
A biotechnology enterprise and company aiming to make drugs at lower prices are collaborating on new lower-cost synthetic protein drugs.
-
Seed Stage Investors Raise $450M for New Fund
A venture capital company specializing in financing start-up enterprises at their earliest stages says it raised $450 million for its third venture fund.